WinstonWınston
MDwerks logo

MDwerks

MDWK
12
Shell Companies · Financial Services
Price
$0.06
+0.00 (+0.00%)
Market Cap
$14.4M
Winston Score
12
Winston is worried
Weak fundamentals across most pillars.

Share count rising — dilution

+1129.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 18.0M (2021) → 221.4M (2025)

MDwerks, Inc. is a small financial services company that has historically focused on providing payment processing and healthcare billing solutions. Its target customers have included medical practices and healthcare providers that need help managing claims, payments, and administrative tasks. The company operates in a niche space where it tries to connect healthcare providers with faster, more efficient ways to get paid.

MDwerks generates revenue by charging fees for its payment and billing services, though the company has struggled to reach consistent profitability. It operates primarily in the United States and carries an extremely small market capitalization, meaning it is considered a micro-cap or shell-stage company. The financials show deeply negative margins, which signals the company is spending far more than it earns — the central risk here is whether MDwerks can find a sustainable business model or a viable acquisition target before it runs out of resources.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-15.5% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-20.0% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (7%)

Research and development spending

Insider Activity

3.1%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~1 months

$95,754 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

MDwerks has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
-31.4%
Thin — -31.4% gross margin
Operating Margin
-143.8%
Losing money on operations — -143.8%
ROCE
-48.2%
Weak — -48.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-2.7%
Shrinking sales (-2.7% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-91.3%
Burning cash (-91.3%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.99
Moderate — manageable debt (0.99)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial